Physician profile
Albert W Steele
NPI 1588771455
$3,309.99
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,220 · 2020: $314 · 2021: $1,279 · 2022: $497.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $466.60 | 2019-2022 | |
| Amgen INC. | $395.07 | 2019-2022 | |
| Abbvie INC. | $370.88 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $215.34 | 2019-2022 | |
| Pfizer INC. | $186.34 | 2019-2021 | |
| Esperion Therapeutics, INC. | $163.53 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $154.78 | 2019-2021 | |
| Allergan, INC. | $152.88 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $151.89 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $144.64 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $120.27 | 2019-2022 | |
| Glaxosmithkline, LLC. | $119.29 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $79.36 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $74.06 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $57.17 | 2019-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $54.01 | 2019-2021 | |
| Abbott Laboratories | $51.93 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $49.25 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $42.90 | 2022 | |
| Amarin Pharma, INC. | $39.96 | 2019 | |
| Lilly USA, LLC | $37.64 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $36.33 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.43 | 2021-2022 | |
| Dexcom, INC. | $24.03 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $19.36 | 2022 | |
| Nestle Healthcare Nutrition INC. | $16.01 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $15.38 | 2019 | |
| Gilead Sciences, INC. | $15.33 | 2020 | |
| Ironwood Pharmaceuticals, INC | $12.36 | 2020 | |
| Genentech USA, INC. | $11.97 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Steele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.